PatientsVille.com Logo

PatientsVille

Valpakine Side Effects

Common Valpakine Side Effects


The most commonly reported Valpakine side effects (click to view or check a box to report):

Convulsion (16)
Product Quality Issue (10)
Alopecia (5)
Confusional State (4)
Fatigue (4)
Somnolence (4)
Tremor (4)
Hyponatraemia (3)
Thrombocytopenia (3)
Vitamin B12 Deficiency (3)
Hypoalbuminaemia (3)
Pneumonia (3)
Pyrexia (3)
Product Odour Abnormal (2)
Inappropriate Affect (2)
Product Taste Abnormal (2)
Speech Disorder (2)
Anaemia Macrocytic (2)
Headache (2)
Skin Discolouration (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Valpakine Side Effects Reported to FDA

The following Valpakine reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Valpakine on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Forceps Delivery
This is a report of a 32-year-old female patient (weight: NA) from BR, suffering from the following symptoms/conditions: cyst, who was treated with Valpakine (dosage: NA, start time: 2006), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Forceps Delivery
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Valpakine treatment in female patients, resulting in forceps delivery side effect.

Product Quality Issue, Dyspnoea, Epilepsy
This report suggests a potential Valpakine Oral Soulution Product Quality Issue, Dyspnoea, Epilepsy side effect(s) that can have serious consequences. A 4-year-old male patient (weight: NA) from BRAZIL was diagnosed with the following symptoms/conditions: cerebral disorder and used Valpakine Oral Soulution (dosage: 30 Drops In The Am, 30 Drops In The Pm) starting Jan 01, 2010. Soon after starting Valpakine Oral Soulution the patient began experiencing various side effects, including:
  • Product Quality Issue
  • Dyspnoea
  • Epilepsy
Drugs used concurrently:
  • Clonazepam
Although Valpakine Oral Soulution demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as product quality issue, may still occur.

Pyrexia, Pneumonia, Somnolence, Confusional State, Fatigue, Alopecia, Tremor, Convulsion
This Pyrexia, Pneumonia, Somnolence, Confusional State, Fatigue, Alopecia, Tremor, Convulsion problem was reported by a health professional from BRAZIL. A 41-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: convulsion. On Oct 19, 2010 this consumer started treatment with Valpakine (dosage: Twice A Day). The following drugs were being taken at the same time:
  • Primidone
  • Lamotrigine
When commencing Valpakine, the patient experienced the following unwanted symptoms/side effects:
  • Pyrexia
  • Pneumonia
  • Somnolence
  • Confusional State
  • Fatigue
  • Alopecia
  • Tremor
  • Convulsion
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as pyrexia, may become evident only after a product is in use by the general population.

Alopecia, Confusional State, Convulsion, Fatigue, Pneumonia, Pyrexia, Somnolence, Tremor
This is a report of a 41-year-old female patient (weight: NA) from BRAZIL. The patient developed the following symptoms/conditions: convulsion and was treated with Valpakine (dosage: Twice A Day) starting Oct 19, 2010. Concurrently used drugs:
  • Primidone
  • Lamotrigine
Soon after that, the consumer experienced the following side effects:
  • Alopecia
  • Confusional State
  • Convulsion
  • Fatigue
  • Pneumonia
  • Pyrexia
  • Somnolence
  • Tremor
The patient was hospitalized. This opens a possibility that Valpakine treatment could cause the above reactions, including alopecia, and some female subjects may be more susceptible.


Alopecia, Confusional State, Convulsion, Fatigue, Pneumonia, Pyrexia, Somnolence, Tremor
A 41-year-old female patient (weight: NA) from BRAZIL with the following symptoms/conditions: convulsion started Valpakine treatment (dosage: Twice A Day) on Oct 19, 2010. Soon after starting Valpakine treatment, the subject experienced various side effects, including:
  • Alopecia
  • Confusional State
  • Convulsion
  • Fatigue
  • Pneumonia
  • Pyrexia
  • Somnolence
  • Tremor
Concurrently used drugs:
  • Primidone
  • Lamotrigine
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Valpakine.

Alopecia, Confusional State, Convulsion, Fatigue, Overweight, Somnolence
A 41-year-old female patient from BRAZIL (weight: NA) experienced symptoms, such as: convulsion and was treated with Valpakine(dosage: NA). The treatment was initiated on Jun 01, 2010. After that a consumer reported the following side effect(s):
  • Alopecia
  • Confusional State
  • Convulsion
  • Fatigue
  • Overweight
  • Somnolence
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Valpakine efficacy:
  • Primidone


Balance Disorder, Initial Insomnia, Syncope, Tremor
In this report, Valpakine was administered for the following condition: NA.A 13-year-old male consumer from BRAZIL (weight: NA) started Valpakine treatment (dosage: NA) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Balance Disorder
  • Initial Insomnia
  • Syncope
  • Tremor
A possible interaction with other drugs could have contributed to this reaction: NA.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Valpakine treatment could be related to the listed above side effect(s).

Convulsion, Product Quality Issue
This is a report of the following Valpakine side effect(s):
  • Convulsion
  • Product Quality Issue
A 34-year-old female patient from FRANCE (weight: NA) presented with the following condition: convulsion and received a treatment with Valpakine (dosage: Gastroresistant Tab) starting: Jan 01, 2008.The following concurrently used drugs could have generated interactions: NA.The patient was hospitalized.This report suggests that a Valpakine treatment could be associated with the listed above side effect(s).

Convulsion, Fall
This Valpakine report was submitted by a 10-year-old female consumer from BRAZIL (weight: NA). The patient was diagnosed with: epilepsy and Valpakine was administered (dosage: 5.5 Unit Daily) starting: Jan 01, 2008. The consumer developed a set of symptoms:
  • Convulsion
  • Fall
Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Valpakine treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Anaemia, Hypoalbuminaemia, Hyponatraemia, Macrocytosis, Thrombocytopenia, Vitamin B12 Deficiency
This is a report of a possible correlation between Valpakine use and the following symptoms/side effect(s):
  • Anaemia
  • Hypoalbuminaemia
  • Hyponatraemia
  • Macrocytosis
  • Thrombocytopenia
  • Vitamin B12 Deficiency
which could contribute to an assessment of Valpakine risk profile.A 4-year-old male consumer from FRANCE (weight: NA) was suffering from infantile spasms and was treated with Valpakine (dosage: NA) starting NS.Other concurrent medications:
  • Clobazam
The patient was hospitalized.

Alopecia, Convulsion, Dry Skin, Dysgeusia, Erythema, Weight Increased
A female patient from BRAZIL (weight: NA) presented with the following symptoms: convulsion and after a treatment with Valpakine (dosage: Gastro-resistant Tablet) experienced the following side effect(s):
  • Alopecia
  • Convulsion
  • Dry Skin
  • Dysgeusia
  • Erythema
  • Weight Increased
The treatment was started on Jan 01, 2009. Valpakine was used in combination with the following drugs:
  • Clonazepam
  • Sertraline Hcl
This report could alert potential Valpakine consumers.

Convulsion, Product Quality Issue
In this report, a 17-year-old female patient from FRANCE (weight: NA) was affected by a possible Valpakine side effect.The patient was diagnosed with convulsion. After a treatment with Valpakine (dosage: NA, start date: Feb 01, 2009), the patient experienced the following side effect(s):
  • Convulsion
  • Product Quality Issue
The following simultaneously used drugs could have led to this reaction:
  • Hidantal
  • Rivotril
The findings here stress that side effects should be taken into consideration when evaluating a Valpakine treatment.

Convulsion, Product Quality Issue, Speech Disorder
This is a report of a 52-year-old male patient from FRANCE (weight: NA), who used Valpakine (dosage: NA) for a treatment of convulsion. After starting a treatment on NS, the patient experienced the following side effect(s):
  • Convulsion
  • Product Quality Issue
  • Speech Disorder
The following drugs could possibly have interacted with the Valpakine treatment NA.Taken together, these observations suggest that a Valpakine treatment could be related to side effect(s), such as Convulsion, Product Quality Issue, Speech Disorder.

Convulsion, Headache, Product Quality Issue, Product Taste Abnormal, Skin Discolouration, Vomiting
This convulsion side effect was reported by a consumer or non-health professional from FRANCE. A 7-year-old female patient (weight:NA) experienced the following symptoms/conditions: convulsion. The patient was prescribed Valpakine (dosage: NA), which was started on Jan 01, 2004. Concurrently used drugs: NA. When starting to take Valpakine the consumer reported the following symptoms:
  • Convulsion
  • Headache
  • Product Quality Issue
  • Product Taste Abnormal
  • Skin Discolouration
  • Vomiting
These side effects may potentially be related to Valpakine.

Convulsion, Inappropriate Affect, Insomnia, Product Odour Abnormal, Product Quality Issue
This is a Valpakine side effect report of a 19-year-old male patient (weight:NA) from FRANCE, suffering from the following symptoms/conditions: convulsion, who was treated with Valpakine (dosage:NA, start time: Jan 01, 2005), combined with: NA., and developed a serious reaction and a convulsion side effect. The patient presented with:
  • Convulsion
  • Inappropriate Affect
  • Insomnia
  • Product Odour Abnormal
  • Product Quality Issue
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Valpakine treatment in male patients suffering from convulsion, resulting in convulsion.

Anaemia Macrocytic, Hypoalbuminaemia, Hyponatraemia, Thrombocytopenia, Vitamin B12 Deficiency
This report suggests a potential Valpakine anaemia macrocytic side effect(s) that can have serious consequences. A 4-year-old male patient from FRANCE (weight:NA) was diagnosed with the following health condition(s): infantile spasms and used Valpakine (dosage: NA) starting NS. Soon after starting Valpakine the patient began experiencing various side effects, including:
  • Anaemia Macrocytic
  • Hypoalbuminaemia
  • Hyponatraemia
  • Thrombocytopenia
  • Vitamin B12 Deficiency
Drugs used concurrently:
  • Clobazam
The patient was hospitalized. Although Valpakine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as anaemia macrocytic, may still occur.

Anaemia Macrocytic, Hypoalbuminaemia, Hyponatraemia, Thrombocytopenia, Vitamin B12 Deficiency
This anaemia macrocytic problem was reported by a consumer or non-health professional from FRANCE. A 4-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): epilepsy.On NS a consumer started treatment with Valpakine (dosage: NA). The following drugs/medications were being taken at the same time:
  • Clobazam
When commencing Valpakine, the patient experienced the following unwanted symptoms /side effects:
  • Anaemia Macrocytic
  • Hypoalbuminaemia
  • Hyponatraemia
  • Thrombocytopenia
  • Vitamin B12 Deficiency
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as anaemia macrocytic, may become evident only after a product is in use by the general population.

Convulsion, Product Quality Issue, Speech Disorder
This is a Valpakine side effect report of a 52-year-old male patient (weight: NA) from FRANCE. The patient developed the following symptoms/conditions: convulsion and was treated with Valpakine (dosage: NA) starting NS. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Convulsion
  • Product Quality Issue
  • Speech Disorder
This opens a possibility that Valpakine could cause convulsion and that some male patients may be more susceptible.

Convulsion, Product Quality Issue
A 17-year-old female patient (weight: NA) from FRANCE with the following symptoms: convulsion started Valpakine treatment (dosage: NA) on Feb 01, 2009. Soon after starting Valpakine treatment, the consumer experienced several side effects, including:
  • Convulsion
  • Product Quality Issue
. Concurrently used drugs:
  • Hidantal
  • Clonazepam
This finding indicates that some patients can be more vulnerable to developing Valpakine side effects, such as convulsion.

Skin Lesion, Stevens-johnson Syndrome, Visual Acuity Reduced
This skin lesion side effect was reported by a consumer or non-health professional from FRANCE. A 13-year-old male patient (weight:NA) experienced the following symptoms/conditions: convulsion.The patient was prescribed Valpakine (dosage: NA), which was started on NS. Concurrently used drugs:
  • Acetylsalicylic Acid
  • Tegretol
.When starting to take Valpakine the consumer reported symptoms, such as:
  • Skin Lesion
  • Stevens-johnson Syndrome
  • Visual Acuity Reduced
These side effects may potentially be related to Valpakine. The patient was hospitalized and became disabled.

Convulsion, Inappropriate Affect, Insomnia, Product Odour Abnormal, Product Quality Issue
This is a report of a 19-year-old male patient (weight: NA) from FRANCE, suffering from the following symptoms/conditions: convulsion, who was treated with Valpakine (dosage: NA, start time: Jan 01, 2005), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Convulsion
  • Inappropriate Affect
  • Insomnia
  • Product Odour Abnormal
  • Product Quality Issue
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Valpakine treatment in male patients, resulting in convulsion side effect.

Convulsion, Headache, Product Quality Issue, Product Taste Abnormal, Skin Discolouration, Vomiting
This report suggests a potential Valpakine Convulsion, Headache, Product Quality Issue, Product Taste Abnormal, Skin Discolouration, Vomiting side effect(s) that can have serious consequences. A 7-year-old female patient (weight: NA) from FRANCE was diagnosed with the following symptoms/conditions: convulsion and used Valpakine (dosage: NA) starting Jan 01, 2004. Soon after starting Valpakine the patient began experiencing various side effects, including:
  • Convulsion
  • Headache
  • Product Quality Issue
  • Product Taste Abnormal
  • Skin Discolouration
  • Vomiting
Drugs used concurrently: NA. Although Valpakine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as convulsion, may still occur.

Accidental Overdose, Agitation, Irritability
This Accidental Overdose, Agitation, Irritability problem was reported by a consumer or non-health professional from FRANCE. A 2-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Jan 12, 2010 this consumer started treatment with Valpakine (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Valpakine, the patient experienced the following unwanted symptoms/side effects:
  • Accidental Overdose
  • Agitation
  • Irritability
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as accidental overdose, may become evident only after a product is in use by the general population.

Decreased Appetite, Weight Decreased
This is a report of a 21-year-old male patient (weight: NA) from FRANCE. The patient developed the following symptoms/conditions: epilepsy and was treated with Valpakine (dosage: NA) starting Dec 01, 2009. Concurrently used drugs:
  • Gardenal
  • Carbamazepine
Soon after that, the consumer experienced the following side effects:
  • Decreased Appetite
  • Weight Decreased
This opens a possibility that Valpakine treatment could cause the above reactions, including decreased appetite, and some male subjects may be more susceptible.

Convulsion, Petit Mal Epilepsy
A 6-year-old male patient (weight: NA) from FRANCE with the following symptoms/conditions: convulsion started Valpakine treatment (dosage: NA) on Jan 01, 2008. Soon after starting Valpakine treatment, the subject experienced various side effects, including:
  • Convulsion
  • Petit Mal Epilepsy
Concurrently used drugs:
  • Urbanil
  • Lamotrigine
The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Valpakine.

1 of 2 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Valpakine Side Effects

    Did You Have a Valpakine Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Valpakine for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Valpakine Safety Alerts, Active Ingredients, Usage Information

    More About Valpakine

    Side Effects reported to FDA: 26

    Valpakine safety alerts: No

    Reported hospitalizations: 13

    Latest Valpakine clinical trials

    Valpakine Reviews

    No reviews, be a first to report a side effect via side effect reporting form